Sanofi Genzyme will lay off 130 workers this week at its manufacturing plant in Boston in an effort to reduce costs and simplify operations, according to the Boston Globe.
The layoffs will only affect employees at the Allston Landing plant, which is a biomanufacturing site.
"We must be flexible in our operations to remain competitive in a dynamic and challenging healthcare environment," said Ashleigh Koss, spokeswoman for Sanofi SA, the French parent company, according to the Boston Globe.
Sanofi Genzyme is a rare disease division of Sanofi SA. It employs about 5,000 employees in Massachusetts.